Gilead Sciences, Inc Patent Portfolio Statistics

Gilead Sciences, Inc.

Profile Summary

This article summarizes the perfomance of the assignee in the recent years. The overall statistics for this portfolio help to analyze the areas where the assignee is performing well. The filing trend, perfomance across the tech centers and the perfomance of the recent applications has been mentioned below. All the stats are calculated based on the perfomance in USPTO.

How does the overall patent portfolio of Gilead Sciences, Inc. look like?

Total Applications: 1,532
Granted Patents: 872
Grant Index 66.97 %
Abandoned/Rejected Applications: 430 (33.03%)
In-Process Applications: 224
Average Grant Time: 2.42 Years
Average Office Actions: 1.36

Which Technology Area Gilead Sciences, Inc. is filing most patents in? (Last 10 years)

Art Unit Definition Total Applications
1624 Organic Chemistry 196
1625 Organic Chemistry 138
1626 Organic Chemistry 128
1623 Organic Chemistry 110
1628 Organic Chemistry 103

How many patents are Gilead Sciences, Inc. filing every year?

Year Total Applications
2022 0*
2021 24*
2020 77
2019 68
2018 87

*The drop in the number of applications filed in last two years compared to previous years is because applications can take up to 18 months to get published

Recently filed patent applications of Gilead Sciences, Inc. in USPTO?

Publication number: US20220009928A1
Application number: 17/353,462

Abstract:
The present invention provides crystalline forms, solvates and hydrates of 4-amino-2-butoxy-8-(3-(pyrrolidin-1-ylmethyl)benzyl)-7,8-dihydropteridin-6(5H)-one, and methods of making.

Publication date: 2022-01-13
Applicant: Gilead Sciences, Inc.
Inventors: Diaz Krista Marie


Publication number: US20220009904A1
Application number: 17/349,288

Abstract:
The present disclosure relates to methods and intermediates useful for preparing a compound of formula I.

or a co-crystal, solvate, salt or combination thereof.

Publication date: 2022-01-13
Applicant: Gilead Sciences, Inc.
Inventors: Lew Willard


How are Gilead Sciences, Inc.’s applications performing in USPTO?

Application Number Title Status Art Unit Examiner
17/353,462 Solid Forms Of A Toll-Like Receptor Modulator OPAP Central, Docket
17/349,288 Methods And Intermediates For Preparing Therapeutic Compounds OPAP Central, Docket